Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 2, 1995, Pages 659-666

  Valcavi, Roberto ^a   Gaddi, Oscar ^b   Zini, Michele ^a   Iavicoli, Mario ^c   Mellino, Umberto ^c   Portioli, Italo ^a  

^a Modulo di Endocrinologia   (Italy)

^b Arcispedale S Maria Nuova   (Italy)

^c Nova Nordisk Italia ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HUMAN; HYPOPITUITARISM; INOTROPISM; MALE; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; BODY SURFACE AREA; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE; HEART; HEART RATE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REST; TIME FACTORS;

EID: 0028843243     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.2.7852533     Document Type: Article

References (28)

1. Rosén T, Bengtsson B-Å. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
2. Merola B, Cittadini A, Colao A, et al. 1993 Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab. 77:1658-1661.
3. Amato G, Carella C, Fazio S, et al. 1993 Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab. 77:1671-1676.
4. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA. 1992 Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J. 67:92-96.
5. Cuneo RC, Wilmhurst P, Lowy C, McGauley G, Sönksen PH. 1989 Cardiac failure responding to growth hormone. Lancet. 1:838-839.
6. Frustaci A, Perrone G A, Gentiloni N, Russo MA. 1992 Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol. 97:503-511.
7. Ghigo E, Mazza E, Imperiale E, et al. 1987 Pyridostigmine plus GHRH is the most powerful single test of the secretory integrity of somatotrophs. Acta Ped Scand. 303(Suppl 1):182-183.
8. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. 1992 The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 37:387-397.
9. Teicholz LE, Kreulen T, Herman MV, Gorlin R. 1976 Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 37:7-11.
10. Devereux RB, Reichek N. 1977 Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 55:613-618.
11. Reicheck N, Wilson J, St John Sutton M, Plappert TA, Goldberg S, Hirshfeld JW. 1982 Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 65:99-108.
12. Sagawa K, Suga H, Shoukas AA, Bakalar KM. 1977 End-systolic pressure/volume ratio: a new index of ventricular contractility. Am J Cardiol. 40:748-753.
13. Sagawa K. 1981 The end-systolic pressure volume relation of the ventricle: definition, modifications and clinical use. Circulation. 63: 1223-1227.
14. Anversa P, Ricci R, Olivetti G. 1986 Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol. 7:1140-1149.
15. Lei L, Rubin S, Fishbein M. 1988 Cardiac architectural changes with hypertrophy induced by excess growth hormone in rats. Lab Invest. 59:357-362.
16. Mather HM, Boyd MJ, Jenkins JS. 1979 Heart size and function in acromegaly. Br Heart J. 41:697-701.
17. Smallridge RC, Rajfer S, Davia J, Schaaf M. 1979 Acromegaly and the heart. An echocardiographic study. Am J Med. 66:22-27.
18. Lim MJ, Barkan AL, Buda AJ. 1992 Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Intern Med. 117:719-726.
19. Caidahl K, Edén S, Bengtsson B-Å. 1994 Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf). 40:393-400.
20. Beshyah AS, Shahi M, Skinner E, Sharp P, Foale R, Johnston DG. 1994 Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol. 130:451-458.
21. Cuneo RC, Salomon F, Wilmshurst P, Byrne C, Wiles CM, Hesp R, Sönksen PH. 1991 Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. Clin Sci. 81:587-592.
22. Jorgensen JOL, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225.
23. Barton JS, Cullen S, Hindmarsh PC, Brooke CGD, Preece MA. 1992 Growth hormone treatment in idiopathic short stature: a preliminary analysis of cardiovascular effects. Acta Paediatr. 383(Suppl): 35-38.
24. Ho KY, Weissberger AJ. 1990 The antinatriuretic action of biosyn-tehtic human growth hormone in man involves activation of the renin-angiotensin system. Metab Clin Exp. 39:133-137.
25. Thuesen L, Christiansen JS, Sorensen KE, Jorgensen JOL, Orskov H, Henningsen P. 1988 Increased myocardial contractility following growth hormone administration in normal man. Dan Med Bull. 35:193-196.
26. Brutsaert DL, Rademakers FE, Sys SU, Gillebert TC, Housmans PR. 1985 Analysis of relaxation in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis. 28:143-163.
27. Dougherty AH, Naccerelli GV, Grey EL, Hicks CH, Golstein RA. 1987 Congestive heart failure with normal systolic function. Am J Cardiol. 54:778-782.
28. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.